Intracranial Pressure or ICP monitors are devices that measure ICP and are commonly placed in any patient in whom there is a concern for elevated ICP. ICP monitors are mainly designed to measure the pressure within the cranium which is affected by accident and trauma. Such devices are usually used to treat traumatic brain injury. It measures the pressure in the skull by placing a minor or small pressure-sensitive probe in the skull, which is attached at the other end to a monitor. It helps to sense the pressure caused inside the skull & transports the measurements to a recording device.
Some signs of raised ICP are a headache, increased blood pressure, nausea, decreased mental abilities, vomiting, double vision, confusion about time and pupils that don't respond to changes in light.
According to the study, “Global Intracranial Pressure (ICP) Monitoring Market Information: by Route of Intervention (Intraventricular, Epidural Sensor), Technique (Invasive, Non-invasive), Application (Traumatic Brain Injury, Subarachnoid Hemorrhage), Device (Intraventricular Catheter, Epidural Sensors), End-user (Hospitals & Clinics), and Region - Global Forecast Till 2024” the key companies operating in the global Intracranial Pressure (ICP) monitoring market areSpiegelberg GmbH & Co. KG, Sophysa SA, RAUMEDIC Inc., Boston Neurosciences, Terumo Corporation, Medtronic Plc., Continental Medtronic Plc., Vittamed, Focus Medical Group Inc., Natus Medical Incorporated, DePuySynthes, Integra LifeSciences Corporation.
Based on the route of intervention, the ICP monitoring market is segmented into the epidural sensor and intraventricular. Based on the mode of devices, the market is segmented into the subarachnoid screw, non-invasive ICP monitors, intraventricular catheter, and epidural sensors. Based on the technique, the market is segmented into invasive techniques and non-invasive techniques. Invasive techniques include micro-transducer and External ventricular drainage (EVD). Non-invasive techniques include transcranial doppler ultrasonography, optic nerve sheath diameter sonography, Tympanic Membrane Displacement (TMD) Analyzer, MRI/CT and fundoscopy (papilledema). Based on application, the market is segmented into traumatic brain injury, subarachnoid hemorrhage, intracerebral hemorrhage, meningitis and others (cerebral edema and CNS infection). In addition, based on end-user, the market is segmented into trauma centers, hospitals & clinics, and others.
The ICP monitoring market is driven by a rise in the prevalence of traumatic brain injuries, followed by favorable reimbursement policies, rise in industrial as well as road accidents, growth in prevalence of neurovascular diseases for instance brain aneurysm, Arteriovenous Malformations (AVMs), and rise in product development & commercialization. However, the high procedural cost of ICP monitoring devices and a shortage of trained professionals may impact the market. Moreover, the increase in the use of endovascular embolization for the treatment of brain aneurysm is a key opportunity for the market.
Based on geography, the North-American region dominates the ICP monitoring market, followed by European region owing to growth in awareness regarding the neurodegenerative disease, presence of rapid growth in economies, increase in number of patients suffering from moderate to severe brain injury and constant initiatives are undertaken by the government for providing a better infrastructure in the region. The Asia Pacific region is estimated to witness substantial growth rate due to the presence of well-established critical care centers & hospitals and a rise in the number of patients who are suffering from brain disorders over the forecast period. In upcoming years, it is projected that the market will be reached at a rapid pace on account of a well-developed healthcare system and growth in technological advancements in medical devices.
Key Players:-
Integra LifeSciences Corporation
DePuy Synthes
Spiegelberg GmbH & Co. KG
RAUMEDIC Inc, Sophysa SA
Boston Neurosciences
Medtronic Plc, Terumo Corporation
And Natus Medical Incorporated
Target Audience
Brain Monitoring Device Manufacturers & Suppliers
Contract Research Organizations (CROs)
Research and Development (R&D) Companies
Government Research Laboratories
Regional Analysis
Americas
North America
US
Canada
South America
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Republic of Korea
Rest of Asia-Pacific
Middle East & Africa
Middle East
Africa
To Know More, Click On The Link Below:-
Related Report:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
